T. Rowe Price Associates’s RayzeBio, Inc. Common Stock RYZB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
Sell
-11,086
Closed -$690K 3000
2023
Q4
$690K Sell
11,086
-1,022,492
-99% -$63.6M ﹤0.01% 2032
2023
Q3
$22.9M Buy
+1,033,578
New +$22.9M ﹤0.01% 884